Welcome to our dedicated page for TOMI Environmental Solutions news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on TOMI Environmental Solutions stock.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global leader in bacteria decontamination and infectious disease control. The company provides advanced environmental solutions for indoor surface decontamination through the manufacturing, sales, service, and licensing of its premier Binary Ionization Technology® (BIT™) platform, marketed under the SteraMist® brand.
TOMI's BIT™ platform, developed in collaboration with the Defense Advanced Research Projects Agency (DARPA) and a major U.S. defense contractor, was initially created to address chemical and biological threats following the 2001 anthrax attacks. The technology utilizes a patented two-step process that activates and ionizes a 7.8% hydrogen peroxide solution to produce a disinfectant mist or fog. This innovation ensures effective sterilization while being safe for use on various materials, including delicate electronics.
The SteraMist® product line includes the SteraMist Surface Unit, SteraMist Environment System, SteraMist Total Disinfection Cart, SteraMist Select Surface Unit, Stainless Steel 90 Degree Applicator, iHP Plasma Decontamination Chamber, SteraMist Custom Engineered System (CES), and iHP Corporate Service Decontamination. These products serve diverse sectors such as hospitals, biosafety labs, pharmaceutical facilities, commercial buildings, schools, and more.
Recently, TOMI conducted a successful study that demonstrated the efficacy of its SteraMist® iHP technology in eliminating the Foot-and-Mouth Disease Virus (FMDV) from both porous and non-porous surfaces. This study, performed under EPA standards, highlights TOMI's commitment to food safety and combating Transboundary Animal Disease (TAD) outbreaks.
In 2023, TOMI expanded its sales infrastructure by onboarding additional distributors and sales representatives, enhancing its domestic and international presence. The company is also focusing on diversifying its product line with innovations like the SteraMist® Hybrid, Transport, and Select Plus units. These efforts are expected to drive revenue growth and strengthen TOMI's market position.
Financially, TOMI has shown resilience despite challenges, with substantial growth in its sales pipeline and backlog. The company is also engaging in significant government relationships and receiving notable orders from sectors like pharmaceuticals and homeland security. These developments are poised to boost TOMI's revenue and market footprint.
TOMI is also committed to cost reduction initiatives to align its cost structure with profitability goals. The company expects a 30% reduction in operational cash use by the end of 2024, aiming for long-term shareholder value while maintaining innovation and growth momentum.
For more information, visit www.steramist.com or contact us at info@tomimist.com.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) recently showcased its Binary Ionization Technology at the RIA 2022 International Restoration Convention in Reno, Nevada, from April 11-13, 2022. The company aims to enhance the visibility of its products and build partnerships with large service companies. A highlight of the event is the introduction of the SteraPak, designed for effective disinfection across various industries. COO Elissa Shane emphasized the importance of strategic partnerships for growth, underlining TOMI’s commitment to expanding market interest in its disinfection solutions.
TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) reported its financial results for Q4 and the full year 2021. The company experienced a revenue decline to $7.8 million from $25.0 million in 2020, attributed to reduced demand post-COVID surge. However, revenues rose by 22% compared to pre-pandemic levels in 2019. The second half of 2021 showed a 20% revenue increase over the first half, attributed to business reopening. Gross margin for 2021 was 59.2%. Despite a net loss of $4.4 million, TOMI highlights growth in solution sales and optimism for 2022 based on increased market interest.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) will release its fourth quarter and full-year 2021 financial results on March 29, 2022, after market close. A conference call is scheduled for 4:30 p.m. ET on the same day. Investors can join the call by dialing (877) 545-0320 (entry code 624594) or accessing via the company’s website. A replay will be available until April 12, 2022. TOMI specializes in disinfection solutions utilizing its Binary Ionization Technology through the SteraMist brand, targeting various commercial sectors.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced an urgent shipment of SteraPak units to Tomimist Hong Kong, aimed at combating the COVID-19 Omicron variant outbreak. Daily cases in Hong Kong have surged to over 58,000. The SteraPak units utilize SteraMist iHP technology, enabling effective disinfection in various commercial settings, enhancing productivity and achieving a six-log kill of infectious diseases without harmful side effects. CEO Dr. Halden Shane emphasized TOMI's readiness to support further needs in Hong Kong as the fight against the virus continues.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has partnered with ARM EnerTech Associates to enhance product development and manufacturing capabilities for its SteraMist brand. This collaboration aims to address the growing demand for automated disinfection solutions, particularly through their Custom Engineered Systems (CES). Recent projects have bolstered TOMI's project pipeline, including two CES projects completed in February and one in early March. This partnership is expected to improve competitive positioning and cost efficiencies by diversifying manufacturing capabilities.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced approximately $1.3 million in orders for its Custom Engineered Systems (CES), including contracts with a Fortune 500 pharmaceuticals company and a leading research facility. This demand reflects a surge in cleanroom utilization in the pharmaceutical sector, prompting a shift to automation in disinfection processes. Despite longer lead times for CES installations, TOMI anticipates revenue realization from these orders in late 2022 and early 2023, driven by increasing sales opportunities and a bolstered technical and R&D team.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a collaboration with On Demand Pharmaceuticals to enhance drug manufacturing through advanced decontamination solutions using TOMI's SteraMist systems. This partnership, leveraging technologies from DARPA, aims to ensure safe production environments in On Demand's modular cleanroom. The Binary Ionization Technology platform provides efficient disinfection, promoting health and safety in pharmaceutical manufacturing. Both companies are committed to innovation in their respective fields, addressing critical needs in health and safety.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced that H.C. Wainwright has initiated analyst coverage of its common stock. This move aims to increase market visibility and enhance the understanding of TOMI's disinfection solutions utilizing its Binary Ionization Technology (BIT). The company emphasizes that analysts' reports reflect their perspectives and not necessarily those of TOMI. The 31-page report is accessible through H.C. Wainwright. TOMI's BIT platform is used widely across various sectors, including healthcare and food processing, underscoring its importance in infection prevention.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has launched the SteraMist Amazon Store, showcasing its SteraPak products utilizing Binary Ionization Technology (BIT). This digital storefront enhances sales channels, making purchasing easier for customers. The SteraPak is designed for various environments, offering efficient disinfection without harmful residues. CEO Dr. Halden Shane emphasized the importance of this initiative in expanding the customer base and protecting against emerging pathogens like the Omicron variant and C. auris fungus.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported Q3 2021 revenues of $2.2 million, a 50% increase from Q2 2021. However, this marked a decline from $4.3 million in Q3 2020. Gross margins fell to 59.6% from 66.0% year-over-year. Operating loss stood at $0.5 million, contrasting with an income of $1.1 million in the same quarter last year. The company's net loss was $0.5 million or $0.03 per share. Recent highlights include expanding their product line with SteraPak and establishing an Amazon store. TOMI remains optimistic for continued growth into Q4 2021 and 2022.
FAQ
What is the current stock price of TOMI Environmental Solutions (TOMZ)?
What is the market cap of TOMI Environmental Solutions (TOMZ)?
What does TOMI Environmental Solutions specialize in?
What is Binary Ionization Technology® (BIT™)?
What sectors use TOMI's products?
What recent achievements has TOMI made?
How is TOMI expanding its market presence?
What financial strategies is TOMI implementing?
Where can I find more information about TOMI?
What is the significance of TOMI's collaboration with DARPA?
What are the primary components of the SteraMist® product line?
How is TOMI contributing to global health?
